Neopterin, a compound derived from GTP, is a percursor molecule of biopterin and is an essential cofactor in neurotransmitter synthesis. It has recently reported that in vivo as well as in vitro immune responses are accompaniced by an increased release of neopterin and that this phenomenon can be used for the biochemical monitoring of diseases accompanied by hyperimmune stimulation. This article describes the immune response-associated neopterin release in the brain, and the possible involvement of microglia.
Introduction
Neopterin IS synthesized from guanosine triphosphate (GTP), which is in a first-step enzymatically cleaved by the GTP cyclohydrolase I to 7,8-dihydroneopterin triphosphate (1) . Macrophages are sources of neopterin. Interferon-y (IFN -y) activates several macrophage functions and induces the secretion of neopterin in human macrophages (2) . The production of neopterin closely correlates with IFN-y concentrations and the activation of cell-mediated immunity (3) . Since the elevated neopterin and 7,8-dihydroneopterin were found in various diseases such as virus infection including human immuno-deficiency virus (HIV) infection, in autoimmune disorders and in certain types of cancer (4, 5) , major effort has been put into the clarification of a possible role of neopterin and 7,8 -dihydroneopterin in cell-mediated immunity. This article focuses on the detection of neopterin in human urine from cancer patients and in normal human brain, and discuss a possible roles of nepterin.
Results and Discussion

Neopterin in urine from cancer patients
Several methods to detect urinary neopterin have been proposed. High-performance liquid chromatography with fluorometry (6), bioassay by Critidia fasciculata (7) , and immunoassays (8, 9) . The polarization fluoroimmunoassay of urinary neopterin and biopterin is based on a homogenous immunoassay and has several practical advantages over established assay methods. The assay is fast, takes only 2 min to read the fluorescence polarization after mixing the sample, FITC-Iabelled pterins, and anti-serum because of no requirement of separation steps (8) .
The levels of urinary neopterin and the ratio of urinary levels of neopterin to those of biopterin are significantly elevated in patients with solid and blood cancers ( Figure. 1 ). Elevated levels of urin ary neopterin have been reported to correlate with those of 6-hydroxymethylpterin, putrescine, and blood cancers ( Figure . ary levels cxeeding the normal upper limit (mean + 2SD) of neopterin. However, patients with values exceeding the normal upper limit (mean + 2SD) of urinary levels of at least one of the neopterin, 6-hydroxymethylpterin, putrescine, or sperrnidne were bearing cancer with almost 100% ( 4). Thus, nearly 100% of cancer patients were positive when both pterins and polyamines were used in combination as biochemical markers of cancer.
The origin of increased urinary neopterin in cancer patients is not clear. One possibility is that neopterin excretion is associated with activation of immune cells such as T-cells (10) and macrophages (11) .
Distribution of neopterin in normal human brains
The tetrahydro form of pterins is required three aromatic amino acid hydroxylases, phenylalanine hydroxylase, tyrosine hydroxylase, and tryptophan hydroxylase as an additional cofactor. These enzymes play an important role in the biosynthesis of biogenic amines such as catecholarnines (dopamine, noradrenaline, and adrenaline) and indoleamines (serotonin and melatonin), which belong to the family of important neurotransmitters and hormones. Neopterin is derived from an intermediate product of L-erythro tetrahydrobiopterin biosythesis from GTP, and L-erythro tetrahydrobiopterin is the natural cofactor for the three aromatic amino acid hydroxylases. Thus, neopterin and L-erythro tetrahydrobiopterin are thought to be localized in the monoaminergic neurons in the brain, and their distribution is thought to be correlated with that of hydroxylases. Using highly SenSITIVe radioimmunoassays of neopterin and biopterin (9), the distribution of neopterin and biopterin was measured in normal human brains, and compared to those of tyrosine hydroxylase activity and tryptophan hydroxylase activity ( Figure. 2).
The distribution of biopterin correlated well with activities of both enzymes, while that of neopterin did not. Moreover, there was no significant correlation of the neopterin. Therefore, neopterin may be localized in a different cell population from monoaminergic neurons. The full extent of the roles of neopterin in the brain is yet unclear, but is thought to be a certain regulator rather than a cofactor (or intermediate product of cofactor biosynthesis).
A possible role of neopterin in the brain
Resident cells within the brain can synthesize, secrete and respond to inflammatory cytokines not only contributing to the response within the brain to injury or immunological challenge, but also regulating their own growth and differentiation potential. This system of communication has been designated as the brain cytokine network (12) . Microglia, macrophage-like cells in the brain, produce and respond to several cytokines (12) including interferon "( (13), and are one of the important cells in the brain immune reaction. When activated by several stimuli such as LPS, interferon ,,(, or phagocytosis, microglia produced superoxide anion and mtnc oxide, which may contribute to neuronal toxicity under SOITle pathophysiological conditions ( 14) . They are thought to produce and secrete neopterin, because of the requireITlent of pterin COITlpounds as cofactors for nitric oxide synthetase (15) . Production of neopterin by microglia was recently reported (16) .
Infection with hUITlan iITlITlUllodeficiency virus type 1 (HIV-l) is frequently complicated in its late stages by the AIDS-deITlentia complex, a neurological syndroITle characterized by abnormalities in cognition, ITlotor perforITlance, and behavior (17) . Microglia are thought to be the priITlary target of HIV-l infection in the brain, because they exclusively express the CD4 antigen (18) which is effectively used for the viral entry (19) . An infection with HIV-l in the brain causes a characteristic lesion of the central nervous systeITl (CNS). This lesion is thought to be related to an activaton of ITlicroglia by viral infection (20) . Soluble factors, such as tumor necrosis factor ex, transforITling growth factor j3 or small proteaseresistant neurotoxic agents, from HIV-infected microglia may contribute to the CNS disfunction in AIDS-dementia complex (21, 22) . An increased neopterin concentration in cerebrospinal fluids was observed in patients with brain HIV-l infection (23, 24) . The role of CSF neopterin is not clear, however, it is important for pathogenesis of the CNS diseases especially in brain viral infection.
Recently, it was demonstrated in a luITlinol assay that neopterin enhances chloraITline-T -and hydrogen peroxide-ITlediated cheITli-luminescence, while 7,8-dihydroneopterin was shown to be a potent scavenger (25) . Furthermore, neopterin was shown to potentiate the toxicity of chloraITline-T against bacteria (25) . In contrast, others reported a supperssion of superoxide-generated NADPHoxidase by neopterin in macrophages sitmulated with phorbol myristate acetate (26) . The confrontation of cells with reactive oxygen intermediates such as superoxide anion or a depletion of cellular antioxidants may result in protericlines/Vol. 6/No. 4 graITlmed cell death or apoptosis (27) . In the brain, many cells die during development and this type of cell eliITlination is important for the conformation of specific neuronal structures. FurtherITlore, ITlicroglial nitric oxide formation plays an important role in pathogenesis of AlzheiITler's disease (14) . It is, therefore, conceivable that brain neopterin, possibly derived from microglia, may regulate the cell viability to maintain an appropriate oxidant-antioxidant balance.
